MrHuze32

MrHuze32

SPHS has been testing it's resistance points higher and higher over the past few months after the sudden gap-down in mid-December of last year. Sophiris Bio Inc., a bio-pharmaceutical company developing PRX302 (topsalysin) for the treatment of urological diseases, has shown a recent development of their PRX302 treatment and doctors say it could serve as a viable...

MrHuze32

SPHS has been testing it's resistance points higher and higher over the past few months after the sudden gap-down in mid-December of last year. Sophiris Bio Inc., a bio-pharmaceutical company developing PRX302 (topsalysin) for the treatment of urological diseases, has shown a recent development of their PRX302 treatment and doctors say it could serve as a viable...

MrHuze32

MagneGas (MNGA) has recently had a large order placed to place acetylene in plants for an unnamed cement company (Argos Cement is being named as the number one suspect for the company who placed the order). This caused the stock to gain 10.1% up to .95 a share from its previous .84 a share. There was also a volume spike due to the breaking news the company issued...